Health and Medical News

Improving Osteoporosis Care Standards Worldwide: Landmark Observational Study

Health and Medical News - Women's Health & Gynecology
Thursday, 10 April 2008
Nearly 60,000 women aged 55 years and older have enrolled in a landmark, multi-national study that will focus on the management of osteoporosis across the globe. Launch of the Global Longitudinal Registry of Osteoporosis in Women (GLOW) was announced at ECCEO 8 (Eighth European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis) in Istanbul, Turkey. This groundbreaking observational study (registry) in osteoporosis aims to gain insights to enhance the standard of care for postmenopausal women at risk of osteoporosis. "We know that there are patients at high risk for osteoporosis, sometimes already having suffered a broken bone, who aren't getting diagnosed and treated. We have to figure out why not," said Dr. Robert Lindsay, GLOW Executive Committee Co-Chair and Chief of Internal Medicine at Helen Hayes Hospital, West Haverstraw, NY. "Globally we have an aging female population that wants to maintain independence and vitality. We can help by finding the key to improving diagnosis and treatment of this debilitating disease." GLOW will monitor tens of thousands of older women who have visited a primary care physician in the past 2 years. Since patient recruitment for GLOW is not linked to osteoporosis diagnosis and does not alter physician practice, the study provides a fine representation of "usual" older women and the bone health care they receive in the real world. Women are participating from 17 cities in 10 countries on 3 continents. "We wish to understand regional differences in physician and patient behavior and how that impacts patient outcomes," said Professor Pierre Delmas, GLOW Executive Committee Co-Chair and Professor of Medicine and Rheumatology, UniversitÃ© Claude Bernard, Lyon, France. "Hopefully, armed with that knowledge we will be able to recommend best practices and enhance the management of osteoporosis worldwide." GLOW is being conducted by The Center for Outcomes Research (COR), University of Massachusetts Medical School (UMMS), with the support of an unrestricted research grant from The Alliance for Better Bone Health. The Alliance for Better Bone Health is a collaboration between sanofi-aventis and Procter & Gamble Pharmaceuticals. "We are grateful for the commitment of the sponsors and scientific advisors to the GLOW project. We anticipate that these data will provide significant info to enhance the quality of lives of women at risk for osteoporotic fractures," said Dr. Fred Anderson, Director of the Center for Outcomes Research and research professor of surgery and medicine at UMMS. ."This pioneering initiative will be the first comprehensive multi-national look into the relationship between risk factors, patient outcomes and treatment patterns for osteoporosis." Milestone data from GLOW will be communicated on an ongoing basis at international medical conferences and through peer-reviewed publications. For more info on GLOW, please visit: http://www.outcomes.org/glow/ About GLOW GLOW is a prospective, longitudinal, observational study of women over 55 years of age who visited a primary care physician during the 2 years previous to the study. Women were recruited through 700 primary care physicians in 17 cities in North America, Europe, and Australia. GLOW will gather info on osteoporosis risk factors, treatment approaches, patient behavior, and fracture outcomes with an yearly patient survey over a 5 year period. GLOW study sites are the following: Lyon, France Paris, France Leuven, Belgium Amsterdam, Netherlands Barcelona, Spain Essen, Germany Verona, Italy Southampton, UK West Haverstraw, NY USA Worcester, MA USA Pittsburgh, PA USA Seattle, WA USA Cincinnati, OH USA Los Angeles, CA USA Birmingham, AL USA Hamilton, Ontario Canada Sydney, Australia About osteoporosis Osteoporosis-related fragility fractures are an international public health complication responsible for increased mortality, functional impairment and added health care costs. Estimates are that between 40 and 50 percent of white women above the age of 50 in North America, Europe and Australia will incur an osteoporosis-related fracture in their lifetime. Although their rates are lower, non-white women and men are also susceptible. Because the likelihood of fragility fractures increases dramatically with age, fracture numbers are projected to rise as the population ages. About the Center for Outcomes Research (COR) COR is based at the University of Massachusetts, Worcester, MA, USA. The mission of COR is to collect and evaluate data that reflect real world practices and outcomes and to provide physicians with confidential reports that permit comparison of their practices to evidence based performance standards. For more info, please visit: http://www.outcomes.org/ Source: Helen Crow University of Massachusetts Medical School

[ Back ]

Latest news in this category:

The Risks and Benefits of Face Wrinkle Fillers That Work
Saturday, 20 December 2008
Every women wants to look nice and the skin is one of the primary organs of our body that requires special care if we require to look young and nice for a long time. In the quest for looking young, women try countless of anti aging creams, wrinkle creams, face wrinkle fillers and other treatments.

A rant regarding Bust Expansion- Does one really require it?
Friday, 05 December 2008
She is doing it, and even that girl over there is doing it, and now my girlfriend is talking about doing it too. One question, Why? Please tell me why? I don't understand why some girls are so steadfast on Breast Expansion.

Irregular or excessive vaginal bleeding Myths and facts
Tuesday, 25 November 2008
Excessive vaginal discharge in way addition to your regular menstrual cycle could be to a certain extent bothersome if proper care is not being taken by you. This bleeding that occurs from the vagina during menstrual periods but is heavier than the normal discharge.

NuvaRing blood clots have generated interest in a class action lawsuit.
Sunday, 07 September 2008
With the number of anecdotal reports from women who claim to have suffered from NuvaRing blood clots on the increase, attorneys and lawyers are investigating the possibility of starting a NuvaRing class action suit against the manufacturers of the drug.

The NuvaRing pulmonary embolism may be worst of many side effects.
Sunday, 07 September 2008
Much attention was given to the risk of developing a NuvaRing pulmonary embolism after the death of a New Jersey mother after using the birth control way. However, NuvaRing side effects go beyond that risk.

Over the Counter Vaginal Yeast Infection Treatments – Are they Effective in Treating Vaginal Yeast I
Monday, 01 September 2008
Yeast infection of the vagina is caused by excessive growth of Candida Ablicans. The general approach has been to look for drugs over the counter to get this treated.

Male Yeast Infection – How to Treat Male Yeast Infection
Monday, 01 September 2008
It is a myth that yeast infection is only general in women. Men are just as likely to acquire yeast infections as women. It regularly occurs in the genital region as sores, redness and rashes in the penis. It also occurs as rashes in the other parts of the skin and as oral thrush in the mouth.

Main Menu

Most popular articles

Latest News